GE Healthcare, Millipore, Serologicals, Harvard, Stanford, Dharmacon, Bio-Rad, bioMerieux, ART, Takara Bio, InVivoScribe, Caliper, Xenogen, Affymetrix, Luminex | GenomeWeb

GE Healthcare's Q2 Revenues Rise 10 Percent, Profits up 18 Percent

GE Healthcare last week said that second-quarter revenues climbed 10 percent as earnings increased 18 percent.

For the quarter ended June 30, GE Healthcare had $4.1 billion in revenues, up from $3.8 billion during the same quarter in 2005.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."